Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,374 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

for
Multiple Sclerosis
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT06410261

Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: Chicago IL, Milwaukee WI, Columbus OH, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase2, Recruiting

Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females

for
Iron Deficiency (ID), Pregnancy
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: Female

Age: 18 - 45

Code: NCT07076849

Phase2, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Chicago IL, Detroit MI, Cincinnati OH, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase2, Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for
Myocarditis Acute, Cancer
Location: Chicago IL, Milwaukee WI, Indianapolis IN, Ann Arbor MI,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05335928

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Chicago IL, Oak Lawn IL, Park Ridge IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

ELEVATE High-Risk PCI Pivotal Study

for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Location: Chicago IL, Milwaukee WI, Detroit MI, Cincinnati OH,
Sponsor: Magenta Medical Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07001332

Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Chicago IL, Milwaukee WI, St Louis MO, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Chicago IL, Milwaukee WI, Peoria IL, Indianapolis IN,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Chicago IL, Maywood IL, Lafayette IN, Grand Rapids MI,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Implementation of Communication Disability Collection and Accommodations in Primary Care Settings

for
Communication Disabilities
Location: Chicago IL, Evanston IL, New York NY, Aurora CO,
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07656584

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Hinsdale IL, Grand Rapids MI, Noblesville IN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL, Salt Lake City UT
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05344833

Phase2, Recruiting

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

for
Persistent Corneal Epithelial Defect,
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT06919081

Phase2, Recruiting

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

for
Liver Diseases
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05264051

Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Chicago IL, Oak Creek WI, New Berlin WI, Milwaukee WI,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Chicago IL, Naperville IL, Grand Rapids MI,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

for
Tardive Dyskinesia
Location: Naperville IL, Grand Rapids MI, Garfield Heights OH,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT03062033

Recruiting

rTMS: A Treatment to Restore Function After Severe TBI

for
Traumatic Brain Injury
Location: Hines IL, Chicago IL
Sponsor: Edward Hines Jr. VA Hospital

Sex: All

Age: 18+

Code: NCT02366754

Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Chicago IL, Zion IL, Decatur IL, Lansing MI, Dayton OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago